Cholera

Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)

Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea

Vaccine- and Infection-derived Correlates of Protection for Cholera

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

Preventative Intervention for Cholera for 7 Days

Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)

Simulation Based Training In Medical Students

Single Dose Azithromycin to Prevent Cholera in Children

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance

Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change

Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi

Co-administration Study of OCV, TCV and MR

Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera

A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults

A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults

Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200

Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™